Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

您现在的位置是: 首页 > 实验方法 > 细胞技术

细胞技术

Targeted Alpha Therapy of Prostate Cancer

2025-03-18 细胞技术 加入收藏
Prostate cancer (PC) is now the second most common cause of death from cancer in

Prostate cancer (PC) is now the second most common cause of death from cancer in men after lung cancer (1 ). Brachytherapy, prostatectomy, or external beam radiation can effect a cure, with a life expectancy of at least 10 yr at diagnosis (2 ). Survival depends on the disease being organ confined, specimen confined, or margin positive, with failure rates of 12, 30, and 60%, respectively. Despite aggressive therapy, a significant percentage of men will die of disseminated disease (3 ). Moreover, radical therapy can have distressing side effects. ranging from surgical mortality, incontinence, impotence, bowel damage, and stricture (4 ).

文章底部广告位

文章评论

加载中~